Merck’s Covid-19 Pill Licensed to U.N.-Backed Nonprofit to Increase Global Supplies
Merck & Co. will license a promising Covid-19 drug to a United Nations-backed nonprofit to provide more supplies to low- and middle-income countries.
The Medicines Patent Pool, which aims to expand poor countries’ access to drugs, will work with multiple drugmakers to produce molnupiravir for 105 nations, including Pakistan, Cambodia and all of Africa, the company and nonprofit said Wednesday.
